Answer
The 300 mg netupitant in Akynzeo capsules increases dexamethasone exposure approximately 2.4-fold, so the oral dexamethasone dose should be reduced by approximately 50% when co-administered.
Sources for this answer
- Akynzeo 300mg/0.5mg hard capsulesChugai Pharma UK Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 7Document updated
Sources checked